Versant Capital Management, Inc - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 204 filers reported holding ARCUS BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2022$20710
-16.7%
0.00%
Q3 2022$012
-7.7%
0.00%
Q2 2022$0130.0%0.00%
Q1 2022$0
-100.0%
130.0%0.00%
Q4 2021$1,000130.0%0.00%
Q3 2021$0130.0%0.00%
Q2 2021$0130.0%0.00%
Q1 2021$0130.0%0.00%
Q4 2020$0130.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$65,241,00019.83%
Octagon Capital Advisors LP 2,095,231$84,794,00016.50%
EcoR1 Capital, LLC 5,523,358$223,530,0007.12%
BVF INC/IL 3,398,067$137,520,0004.99%
PFM Health Sciences, LP 3,431,010$138,853,0004.73%
Alphabet Inc. 2,563,441$103,742,0002.50%
Boxer Capital, LLC 1,432,200$57,961,0002.25%
PARK CIRCLE Co 64,000$2,590,0002.04%
SECTORAL ASSET MANAGEMENT INC 283,210$11,462,0001.72%
DAFNA Capital Management LLC 117,200$4,743,0001.19%
View complete list of ARCUS BIOSCIENCES INC shareholders